Literature DB >> 10375456

Effects of antimetabolite induced cellular growth arrest on fibroblast-fibroblast interactions.

J T Daniels1, N L Occleston, J G Crowston, P T Khaw.   

Abstract

The use of single five-minute applications of antimetabolites during glaucoma filtration surgery has significantly reduced the occurrence of post-operative scarring and bleb failure. However, surgery for some patients is still unsuccessful, despite the use of antiproliferative agents, due to formation of scar tissue at the drainage site. It is not known if cells growth arrested in the treated area with a single application of antimetabolites influence the activity of adjacent non-treated cells. We hypothesise that the activity of non-treated cells recruited to the wound site may be involved in post-operative scarring. The aim of this study was to investigate the effects of antimetabolite induced cellular growth arrest on cell-cell interactions using in vitro techniques.Tenon's capsule fibroblast cultures were growth arrested by exposure for 5 minutes to mitomycin-C (0.001, 0.01 and 0.1 mg ml-1), 5-fluorouracil (0.25, 2.5 and 25 mg ml-1) or phosphate buffered saline (PBS). Following a period of serum-starvation, conditioned media (CM) were subsequently collected from the cells at intervals up to 29 days post-treatment. Correction for cell number was made prior to supplementation of serum-free medium with CM. CM were assessed for ability to support or inhibit normal non-treated fibroblast proliferation, migration and collagen contraction. Conditioned media collected from cells growth arrested with MMC or 5FU stimulated normal fibroblast proliferation, migration and collagen contraction in excess of non-conditioned serum-free medium. Peaks of fibroblast activity in CM differed according to which drug and concentration had originally been given to the treated cells. This study has demonstrated that CM collected from fibroblasts treated for 5 minutes with a range of concentrations of antimetabolites can differentially influence normal non-treated fibroblast activity. This in vitro data suggests that despite entering growth arrest, fibroblasts may still influence the behaviour of other cells via soluble mediators. They may have implications in the clinical setting, in that it may not be sufficient to suppress proliferation alone to prevent fibroblast behaviour associated with scarring after glaucoma filtration surgery. Copyright 1999 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10375456     DOI: 10.1006/exer.1999.0684

Source DB:  PubMed          Journal:  Exp Eye Res        ISSN: 0014-4835            Impact factor:   3.467


  6 in total

1.  Effects of daunorubicin, mitomycin C, azathioprine and cyclosporin A on human retinal pigmented epithelial, corneal endothelial and conjunctival cell lines.

Authors:  Justus G Garweg; Maria Wegmann-Burns; David Goldblum
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2005-08-10       Impact factor: 3.117

2.  The study of chemiluminescence in gastric and colonic carcinoma cell lines treated by anti-tumor drugs.

Authors:  Che Chen; Fu-Kun Liu; Xiao-Ping Qi; Jie-Shou Li
Journal:  World J Gastroenterol       Date:  2003-02       Impact factor: 5.742

3.  Mycophenolate mofetil inhibits human Tenon fibroblast proliferation by guanosine depletion.

Authors:  C Heinz; K Heise; T Hudde; K-P Steuhl
Journal:  Br J Ophthalmol       Date:  2003-11       Impact factor: 4.638

Review 4.  A Critical Overview of the Biological Effects of Mitomycin C Application on the Cornea Following Refractive Surgery.

Authors:  Esther Arranz-Marquez; Andreas Katsanos; Vassilios P Kozobolis; Anastasios G P Konstas; Miguel A Teus
Journal:  Adv Ther       Date:  2019-03-11       Impact factor: 3.845

5.  Human tissue factor pathway inhibitor-2 suppresses the wound-healing activities of human Tenon's capsule fibroblasts in vitro.

Authors:  Yuan Jing; Yu Jian-Xiong
Journal:  Mol Vis       Date:  2009-11-12       Impact factor: 2.367

6.  Functional proteomics of failed filtering blebs.

Authors:  Takashi Kanamoto; Nazariy Souchelnytskyi; Yoshiaki Kiuchi
Journal:  Mol Vis       Date:  2009-12-15       Impact factor: 2.367

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.